相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Raffinose from Costus speciosus attenuates lipid synthesis through modulation of PPARs/SREBP1c and improves insulin sensitivity through PI3K/AKT
Padmanaban Muthukumaran et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2018)
In depth understanding of adverse ventricular remodeling after acute myocardial infarction
Christoph Brenner
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
Dynamic role of the transmembrane glycoprotein CD36 (SR-B2) in cellular fatty acid uptake and utilization
Jan F. C. Glatz et al.
JOURNAL OF LIPID RESEARCH (2018)
Cardiac metabolism - A promising therapeutic target for heart failure
Hannah Noordali et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Multitarget Effects of Danqi Pill on Global Gene Expression Changes in Myocardial Ischemia
Qiyan Wang et al.
INTERNATIONAL JOURNAL OF GENOMICS (2018)
Post-Myocardial Infarction Heart Failure
M. Cecilia Bahit et al.
JACC-HEART FAILURE (2018)
The role of cardiac energy metabolism in cardiac hypertrophy and failure
Tomi Tuomainen et al.
EXPERIMENTAL CELL RESEARCH (2017)
Glucose transporters in healthy heart and in cardiac disease
Leszek Szablewski
INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)
High density lipoprotein (HDL) reverses palmitic acid induced energy metabolism imbalance by switching CD36 and GLUT4 signaling pathways in cardiomyocyte
Su-Ying Wen et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2017)
The potential role of mitochondrial ATP synthase inhibitory factor 1 (IF1) in coronary heart disease: a literature review
Serban Maierean et al.
LIPIDS IN HEALTH AND DISEASE (2017)
Imaging of Myocardial Ischemia-Reperfusion Injury Using Sodium [18F]Fluoride Positron Emission Tomography/Computed Tomography in Rats and Humans
Hongyoon Choi et al.
MOLECULAR IMAGING (2017)
PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part II: PPAR-ß/δ and PPAR-γ
Lu Han et al.
FUTURE CARDIOLOGY (2017)
The Key Roles of GSK-3 beta in Regulating Mitochondrial Activity
Kai Yang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Qiliqiangxin Attenuates Adverse Cardiac Remodeling after Myocardial Infarction in Ovariectomized Mice via Activation of PPAR gamma
Shutong Shen et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
CD36 is essential for endurance improvement, changes in whole-body metabolism, and efficient PPAR-related transcriptional responses in the muscle with exercise training
Mark Christian C. Manio et al.
PHYSIOLOGICAL REPORTS (2017)
Metabolic Modulators in Heart Disease: Past, Present, and Future
Gary D. Lopaschuk
CANADIAN JOURNAL OF CARDIOLOGY (2017)
Role of glycogen synthase kinase following myocardial infarction and ischemia-reperfusion
S. Ghaderi et al.
APOPTOSIS (2017)
From fat to FAT (CD36/SR-B2): Understanding the regulation of cellular fatty acid uptake
Jan F. C. Glatz et al.
BIOCHIMIE (2017)
The Biochemistry and Physiology of Mitochondrial Fatty Acid beta-Oxidation and Its Genetic Disorders
Sander M. Houten et al.
ANNUAL REVIEW OF PHYSIOLOGY, VOL 78 (2016)
Hypoxia-driven glycolytic and fructolytic metabolic programs: Pivotal to hypertrophic heart disease
Peter Mirtschink et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2016)
Effect of DanQi Pill on PPARα, lipid disorders and arachidonic acid pathway in rat model of coronary heart disease
Hong Chang et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2016)
The effect of Chinese herbs and its effective components on coronary heart disease through PPARs-PGC1α pathway
Qiyan Wang et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2016)
The Role of Mitochondrial Dysfunction in Heart Failure and Potential Therapeutic Targets
Marko D. Banovic et al.
CURRENT PHARMACEUTICAL DESIGN (2016)
Metabolic support for the heart: complementary therapy for heart failure?
Ward A. Heggermont et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
MicroRNA and receptor mediated signaling pathways as potential therapeutic targets in heart failure
Antonino Tuttolomondo et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2016)
Signaling pathways involved in cardiac energy metabolism
Dipanjan Chanda et al.
FEBS LETTERS (2016)
Novel molecular mechanisms and regeneration therapy for heart failure
Toru Oka et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2016)
The Emerging Role of Metabolomics in the Diagnosis and Prognosis of Cardiovascular Disease
John R. Ussher et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Qishen granules inhibit myocardial inflammation injury through regulating arachidonic acid metabolism
Chun Li et al.
SCIENTIFIC REPORTS (2016)
Danqi Pill regulates lipid metabolism disorder induced by myocardial ischemia through FATP-CPTI pathway
Yong Wang et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2015)
Cardiac remodeling in a new pig model of chronic heart failure: Assessment of left ventricular functional, metabolic, and structural changes using PET, CT, and echocardiography
Miikka Tarkia et al.
JOURNAL OF NUCLEAR CARDIOLOGY (2015)
DanQi Pill protects against heart failure through the arachidonic acid metabolism pathway by attenuating different cyclooxygenases and leukotrienes B4
Yong Wang et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2014)
Qishenyiqi Protects Ligation-Induced Left Ventricular Remodeling by Attenuating Inflammation and Fibrosis via STAT3 and NF-κB Signaling Pathway
Chun Li et al.
PLOS ONE (2014)
Activator or inhibitor? GSK-3 as a new drug target
Fumi Takahashi-Yanaga
BIOCHEMICAL PHARMACOLOGY (2013)
分享论文
